Antioxidants as Protection against Reactive Oxidative Stress in Inflammatory Bowel Disease

Metabolites. 2023 Apr 18;13(4):573. doi: 10.3390/metabo13040573.

Abstract

Inflammatory bowel disease (IBD) belongs to a group of chronic diseases characterised by periods of exacerbation and remission. Despite many studies and observations, its aetiopathogenesis is still not fully understood. The interactions of genetic, immunological, microbiological, and environmental factors can induce disease development and progression, but there is still a lack of information on these mechanisms. One of the components that can increase the risk of occurrence of IBD, as well as disease progression, is oxidative stress. Oxidative stress occurs when there is an imbalance between reactive oxygen species (ROS) and antioxidants. The endogenous and exogenous components that make up the body's antioxidant defence can significantly affect IBD prophylaxis and reduce the risk of exacerbation by neutralising and removing ROS, as well as influencing the inflammatory state.

Keywords: Crohn’s disease; antioxidants; inflammatory bowel disease; nutrients; oxidative stress; ulcerative colitis.

Publication types

  • Review

Grants and funding

This research received no external funding.